Greg Wiessner

Healthcare

Limited coverage. Only 4 questions of coverage. Treat these numbers as directional — sample too small for reliable averages.

Companies

Questions

Challenge RatePercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions.

Challenge Trend

Q1 '25Q4 '25

Focus Areas6 topics

Demand2Revenue Growth2Capital Allocation1Cost Pressure1Product Launch1Competitive Dynamics1

Trends4 quarters

Questions per Quarter

Questions

Challenging

Companies Covered

Question History4 questions

MRNAModerna4 quarters

2025 Q4

Some investors have been surprised by the higher-than-expected cash balance at year-end. So can you explain why that occurred

Capital AllocationCost PressureView in transcript →

2025 Q3

how do you expect the split between these 2 vaccines to continue to evolve? And I'd also be interested to hear what feedback you're hearing from pharmacists

Product LaunchCompetitive DynamicsView in transcript →

2025 Q2

Do you have any early indications of what demand for COVID vaccines might look like this upcoming fall and winter season based on interactions with customers

DemandRevenue GrowthView in transcript →

2025 Q1

Do you have any early indications of what demand for COVID vaccines might look like this upcoming fall and winter season

DemandRevenue GrowthView in transcript →